6.
Fracanzani A, Conte D, Fraquelli M, Taioli E, Mattioli M, Losco A
. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology. 2001; 33(3):647-51.
DOI: 10.1053/jhep.2001.22506.
View
7.
van Sprundel R, van den Ingh T, Schotanus B, van Wolferen M, Penning L, Rothuizen J
. Cellular characteristics of keratin 19-positive canine hepatocellular tumours explain its aggressive behaviour. Vet Rec Open. 2017; 4(1):e000212.
PMC: 5663258.
DOI: 10.1136/vetreco-2016-000212.
View
8.
Siegal-Willott J, Heard D, Sliess N, Naydan D, Roberts J
. Microchip-associated leiomyosarcoma in an Egyptian fruit bat (Rousettus aegyptiacus). J Zoo Wildl Med. 2007; 38(2):352-6.
DOI: 10.1638/1042-7260(2007)038[0352:MLIAEF]2.0.CO;2.
View
9.
Stasiak I, Smith D, Ganz T, Crawshaw G, Hammermueller J, Bienzle D
. Iron storage disease (hemochromatosis) and hepcidin response to iron load in two species of pteropodid fruit bats relative to the common vampire bat. J Comp Physiol B. 2018; 188(4):683-694.
DOI: 10.1007/s00360-018-1155-4.
View
10.
Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M
. Immunoassay for human serum hepcidin. Blood. 2008; 112(10):4292-7.
DOI: 10.1182/blood-2008-02-139915.
View
11.
Bradford C, Jennings R, Ramos-Vara J
. Gastrointestinal leiomyosarcoma in an Egyptian fruit bat (Rousettus aegyptiacus). J Vet Diagn Invest. 2010; 22(3):462-5.
DOI: 10.1177/104063871002200324.
View
12.
Chege S, Vissiennon T, Cavero T, Kinne J, Toosy A
. A RARE CASE OF HEPATOCELLULAR CARCINOMA IN THE ARABIAN SAND CAT (FELIS MARGARITA HARRISONI). J Zoo Wildl Med. 2015; 46(4):699-703.
DOI: 10.1638/2015-0062.1.
View
13.
Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J
. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology. 2006; 49(2):138-51.
DOI: 10.1111/j.1365-2559.2006.02468.x.
View
14.
Paganoni R, Lechel A, Vujic Spasic M
. Iron at the Interface of Hepatocellular Carcinoma. Int J Mol Sci. 2021; 22(8).
PMC: 8071427.
DOI: 10.3390/ijms22084097.
View
15.
Blanc J, de Ledinghen V, Bernard P, de Verneuil H, Winnock M, Le Bail B
. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol. 2000; 32(5):805-11.
DOI: 10.1016/s0168-8278(00)80250-0.
View
16.
Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H
. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003; 94(10):851-7.
PMC: 11160230.
DOI: 10.1111/j.1349-7006.2003.tb01366.x.
View
17.
Maeda T, Adachi E, Kajiyama K, Takenaka K, Sugimachi K, Tsuneyoshi M
. Proliferative activity in intrahepatic metastasis of hepatocellular carcinoma. J Gastroenterol Hepatol. 1996; 11(8):752-7.
DOI: 10.1111/j.1440-1746.1996.tb00326.x.
View
18.
Shafizadeh N, Ferrell L, Kakar S
. Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum. Mod Pathol. 2008; 21(8):1011-8.
DOI: 10.1038/modpathol.2008.85.
View
19.
Leone A, Crawshaw G, Garner M, Frasca Jr S, Stasiak I, Rose K
. A RETROSPECTIVE STUDY OF THE LESIONS ASSOCIATED WITH IRON STORAGE DISEASE IN CAPTIVE EGYPTIAN FRUIT BATS (ROUSETTUS AEGYPTIACUS). J Zoo Wildl Med. 2016; 47(1):45-55.
DOI: 10.1638/2015-0224.1.
View
20.
Almeida J, Iriabho E, Gorrepati V, Wilkinson S, Gruneberg A, Robbins D
. ImageJS: Personalized, participated, pervasive, and reproducible image bioinformatics in the web browser. J Pathol Inform. 2012; 3:25.
PMC: 3424663.
DOI: 10.4103/2153-3539.98813.
View